These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22370302)

  • 21. Acute development of cortical porosity and endosteal naïve bone formation from the daily but not weekly short-term administration of PTH in rabbit.
    Yamane H; Takakura A; Shimadzu Y; Kodama T; Lee JW; Isogai Y; Ishizuya T; Takao-Kawabata R; Iimura T
    PLoS One; 2017; 12(4):e0175329. PubMed ID: 28394900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evidence in the treatment of osteoporosis using weekly teriparatide injections].
    Nakamura Y
    Clin Calcium; 2012 Mar; 22(3):407-13. PubMed ID: 22370308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repetition of continuous PTH treatments followed by periodic withdrawals exerts anabolic effects on rat bone.
    Etoh M; Yamaguchi A
    J Bone Miner Metab; 2010 Nov; 28(6):641-9. PubMed ID: 20393760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
    Cupp ME; Nayak SK; Adem AS; Thomsen WJ
    J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone.
    Hock JM; Gera I
    J Bone Miner Res; 1992 Jan; 7(1):65-72. PubMed ID: 1532281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Potential use of parathyroid hormone (PTH) in the treatments for oral diseases].
    Tanaka S; Hata K; Yoneda T
    Clin Calcium; 2012 Jan; 22(1):75-82. PubMed ID: 22201102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
    Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
    Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
    van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
    Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study.
    Ohtori S; Inoue G; Orita S; Yamauchi K; Eguchi Y; Ochiai N; Kishida S; Kuniyoshi K; Aoki Y; Nakamura J; Ishikawa T; Miyagi M; Kamoda H; Suzuki M; Kubota G; Sakuma Y; Oikawa Y; Inage K; Sainoh T; Takaso M; Ozawa T; Takahashi K; Toyone T
    Spine (Phila Pa 1976); 2012 Nov; 37(23):E1464-8. PubMed ID: 22872218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into the role of teriparatide.
    Resmini G; Iolascon G
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):30-2. PubMed ID: 21970914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evidence for osteoporosis treatment using PTH (1-34) daily subcutaneous injection].
    Yamamoto T; Hamaya E; Sowa H
    Clin Calcium; 2012 Mar; 22(3):399-406. PubMed ID: 22370307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent enhancement of spinal fusion in rats with teriparatide (PTH[1-34]).
    Ming N; Cheng JT; Rui YF; Chan KM; Kuhstoss S; Ma YL; Sato M; Wang Y; Li G
    Spine (Phila Pa 1976); 2012 Jul; 37(15):1275-82. PubMed ID: 22281479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biased agonism at the parathyroid hormone receptor: a demonstration of functional selectivity in bone metabolism.
    Bohinc BN; Gesty-Palmer D
    Mini Rev Med Chem; 2012 Aug; 12(9):856-65. PubMed ID: 22681253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass?
    Gesty-Palmer D; Luttrell LM
    Br J Pharmacol; 2011 Sep; 164(1):59-67. PubMed ID: 21506957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells.
    Rickard DJ; Wang FL; Rodriguez-Rojas AM; Wu Z; Trice WJ; Hoffman SJ; Votta B; Stroup GB; Kumar S; Nuttall ME
    Bone; 2006 Dec; 39(6):1361-72. PubMed ID: 16904389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis.
    Williams AJ; Jordan F; King G; Lewis AL; Illum L; Masud T; Perkins AC; Pearson RG
    Int J Pharm; 2018 Jan; 535(1-2):113-119. PubMed ID: 29038066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats.
    Schmitt CP; Hessing S; Oh J; Weber L; Ochlich P; Mehls O
    Kidney Int; 2000 Apr; 57(4):1484-92. PubMed ID: 10760084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of PTH on bone structural properties].
    Ito M
    Clin Calcium; 2012 Mar; 22(3):335-41. PubMed ID: 22370300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.